Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
4.000
-0.110 (-2.68%)
Jun 11, 2026, 11:00 AM CST
Market Cap4.47B -2.5%
Revenue (ttm)2.37B -2.8%
Net Income-270.08M
EPS-0.25
Shares Out 1.09B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,105,500
Open4.150
Previous Close4.110
Day's Range3.990 - 4.150
52-Week Range3.990 - 6.740
Beta0.36
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1998
Employees 2,962
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2025, SHE:002793's revenue was 2.27 billion, a decrease of -14.12% compared to the previous year's 2.65 billion. Losses were -288.58 million, -70.11% less than in 2024.

Financial Statements